Global Health Limited IPO
Global Health IPO Review
Global Health Limited (Medanta) is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India amongst the players that operate in the North and East regions of India in terms of bed capacity and operating revenues, as of and for the financial year ended March 31, 2022. Global healthcare was established in the year 2009 as Medanta and it serves under the brand name ‘Medanta’.
Global Health Products and Services
Medanta has key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology etc. according to CRISIL Report. It also provides Air Ambulance facility and various advanced technologies.
They have a network of five hospitals currently operating in (Gurugram, Indore, Ranchi, Lucknow and Patna) and one hospital (Noida), which is under construction.
Medanta is the most popular and reputed healthcare brand and as per its balance sheet and performance, it is growing continuously. Investors can think to apply for this IPO.